Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Classement en actions #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Prix de l'action
$0.2219522
Dernière synchronisation: 2025-09-11
Capitalisation boursière
$1.10B
Changement (1 jour)
0.04%
Changement (1 an)
0.17%
Pays
CN
Échange Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Revenus pour Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Revenus en Sep 2024 TTM : $11.64B
Selon les derniers rapports financiers de Hubei Biocause Pharmaceutical Co., Ltd., le chiffre d'affaires actuel de l'entreprise (TTM) est de $11.64B. En 2022, l'entreprise a réalisé un chiffre d'affaires de $7.19B une diminution par rapport à le chiffre d'affaires de l'année 2021, qui était de $7.80B. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Hubei Biocause Pharmaceutical Co., Ltd. de 2000 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
2026 (TTM) $11.64B 65.85%
2023 $7.02B -2.39%
2022 $7.19B -7.80%
2021 $7.80B 16.95%
2020 $6.67B -7.46%
2019 $7.21B 60.19%
2018 $4.50B -45.18%
2017 $8.21B 235.32%
2016 $2.45B 2,837.70%
2015 $83.33M -36.00%
2014 $130.20M -18.41%
2013 $159.58M 27.62%
2012 $125.04M -30.47%
2011 $179.84M -5.88%
2010 $191.07M 35.24%
2009 $141.29M 6.03%
2008 $133.26M 16.42%
2007 $114.46M 59.34%
2006 $71.83M 11.78%
2005 $64.26M 14.85%
2004 $55.95M 9.55%
2003 $51.07M 21.26%
2002 $42.12M -2.10%
2001 $43.02M 10.51%
2000 $38.93M 0.00%
Revenus d’entreprises similaires ou concurrentes